Hepatocellular carcinoma: Assessment of response to transarterial chemoembolization with image subtraction
β Scribed by Sooah Kim; Lorenzo Mannelli; Cristina H. Hajdu; James S. Babb; Timothy W.I. Clark; Elizabeth M. Hecht; Bachir Taouli
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 363 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Purpose:
To assess the diagnostic accuracy of image subtraction compared with nonsubtracted images obtained with contrastβenhanced T1βweighted imaging (CE T1WI) for the diagnosis of hepatocellular carcinoma (HCC) necrosis after transarterial chemoembolization (TACE), using liver explant as the reference standard.
Materials and Methods:
Thirtyβfour patients who underwent TACE within 90 days of liver transplantation and CE MRI scans were assessed by two independent observers who determined the percentage of tumor necrosis using nonsubtracted and subtracted postcontrast phases. Histopathologic percentage of necrosis was retrospectively determined by an experienced pathologist. Spearman rank correlation test was used to correlate the percentages of necrosis from MR evaluation and from pathology. Receiver operating characteristics curve analysis was performed to determine the performance of subtracted versus nonsubtracted datasets for the diagnosis of complete tumor necrosis.
Results:
There were 57 HCCs (mean size, 2.4 cm; range, 1.2β4.2 cm) diagnosed at explant and identified on MRI, including 16 completely necrotic HCCs. Subtraction demonstrated better interobserver agreement than nonsubtraction dataset for the diagnosis of tumor necrosis. There was a strong correlation between image subtraction and histopathologic assessment of necrosis (r = 0.80β0.86, depending on the phase, P < 0.0001). Subtraction demonstrated significantly higher sensitivity and accuracy for the diagnosis of complete tumor necrosis compared with nonsubtracted dataset.
Conclusion:
Image subtraction enables accurate assessment of necrosis of HCC after TACE with the best accuracy observed at the arterial phase. J. Magn. Reson. Imaging 2010; 31: 348β355. Β© 2010 WileyβLiss, Inc.
π SIMILAR VOLUMES
Criteria to select patients with hepatocellular carcinoma (HCC) for liver transplantation (LT) are based on tumor size and number of nodules rather than on tumor biology. The present study was undertaken to assess the role of transarterial chemoembolization (TACE) in selecting patients with tumors s
## Comparison of 7 Staging Systems for Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization I n a recent article in Cancer, Cho and colleagues 1 suggested that the Cancer of the Liver Italian Program (CLIP) system was the best prognostic system for predicting the survi
## Abstract ## BACKGROUND. Many liver staging systems have been proposed for patients with hepatocellular carcinoma after locoregional therapy; however, controversies persist regarding which system is the best. In this study, the authors compared the performance of 7 staging systems in a cohort of
## Comparison of 7 Staging Systems for Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization I n a recent article in Cancer, Cho and colleagues 1 suggested that the Cancer of the Liver Italian Program (CLIP) system was the best prognostic system for predicting the survi
It has been shown previously that erythropoietin expression in uitro by hepatoma cells increases in response to hypoxia. To verify whether hypoxia of the tumor might result in hepatic release of erythropoietin in uiuo, serum erythropoietin concentrations were measured immunoenzymatically in 12 patie